VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
94.35
3.99 (4.42%)
At close: Oct 01, 2025, 1:45 PM
4.42% (1D)
| Bid | 94.34 |
| Market Cap | 1.09B |
| AUM | 531.7M |
| NAV | 87.33 |
| EPS (ttm) | 4.14 |
| PE Ratio (ttm) | 22.79 |
| Shares Out | 11.55M |
| Inception Date | Dec 19, 2011 |
| Ask | 94.36 |
| Volume | 1,748,672 |
| Open | 90.84 |
| Previous Close | 90.36 |
| Day's Range | 90.84 - 94.36 |
| 52-Week Range | 77.67 - 95.27 |
| Holdings | 26 |
| Expense Ratio | 0.36% |
About PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol PPH
Inception Date Dec 19, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.84% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 19.54% |
| Novartis Ag | NVS | 9.70% |
| Novo Nordisk A/s | NVO | 7.97% |
| Merck & Co., Inc. | MRK | 7.18% |
| Pfizer Inc. | PFE | 4.93% |
| Mckesson Corporation | MCK | 4.93% |
| Abbvie Inc. | ABBV | 4.82% |
| Johnson & Johnson | JNJ | 4.72% |
| Gsk Plc | GSK | 4.63% |
| Sanofi | SNY | 4.42% |
Dividends Dividend Yield 2.21%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jul 1, 2025 | $0.6069 | Jul 7, 2025 |
| Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
| Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
| Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
| Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
2 months ago · seekingalpha.com
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And CenterI maintain a hold rating on PPH due to attractive valuation but weak technical momentum and underperformance versus the S&P 500. Eli Lilly and Johnson & Johnson, PPH's largest holdings, are facing uni...